mRNA can encode virtually any protein. But its true potential hinges on delivering the right sequence to the right tissues at the right time. With precise targeting and selectivity, a new range of therapeutic applications becomes possible for mRNA.
This is the “kernal” of mRNA 2.0.
Our mRNA 2.0 platform uses intelligently programmed mRNA that is precisely delivered and selectively translated in the target cells — creating a new standard of care in oncology and immunology.
See how it works